PITAVASTATIN CALCIUM

Generic: PITAVASTATIN CALCIUM

Zydus Lifesciences LimitedManufacturer
ORALRoute
PITAVASTATIN CALCIUMActive Substance
2023-02-22Original Approval

PITAVASTATIN CALCIUM is FDA application ANDA206047, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
MYALGIA
445 reports
2
DIARRHOEA
350 reports
3
DIZZINESS
305 reports
4
DYSPNOEA
298 reports
5
NAUSEA
298 reports
6
HEADACHE
295 reports
7
DECREASED APPETITE
293 reports
8
FATIGUE
293 reports
9
MALAISE
285 reports
10
PRURITUS
285 reports